RealTalk MS

Episode 40: An MS Activist Is Running for Office with Marques Jones


MS Activist Marques Jones is running for public office in his home state of Virginia. Marques and I sat down to discuss how his role as an MS Activist led to his candidacy, and how his MS diagnosis has continued to inform his business life and his political life.

Marques Jones

We're also talking about the existential threat that now exists for people with pre-existing medical conditions in the U.S., how the MSAA can provide financial assistance for your MRI exam, how Ocrevus may delay the need for a wheelchair for 7 years, and the first clinical trial that's been designed to recognize the needs of severely disabled MS patients.

We have a lot to talk about! Are you ready for RealTalk MS?
____________

The Trump Administration Has Asked a Federal Judge to Eliminate ACA Protections for People Living With Pre-Existing Conditions  1:30

The Multiple Sclerosis Association of America Expands MRI Access Fund  9:32

Ocrevus May Delay the Need for a Wheelchair for 7 Years  10:47

Genentech Announces 1st Clinical Trial to Recognize Needs of Severely Disabled MS Patients  12:05

Interview with MS Activist and Virginia State Senate Candidate Marques Jones  14:53

___________

LINKS
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com

Legal Brief Filed in U.S. District Court by the National MS Society, American Cancer Society, the American Diabetes Association, the American Heart Association, and the American Lung Association

Sign Up to Be an MS Activist

MSAA MRI Access Fund Details & Application

Ocrevus May Delay Need for a Wheelchair by 7 Years

First Clinical Trial to Recognize the Needs of Severely Disabled MS Patients

Marques Jones For Virginia Senate

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 40
Guest: Marques Jones
Hosted By: Jon Strum

Tags: MS, MultipleSclerosis, ProtectPatientsNow, MSActivist, MSAA, Ocrevus, NewPath, RealTalkMS